EOS imaging Announces First Installation of EOS system in a Private German Medical Center

Regulatory News:

EOS Imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the installation of its EOS system at the private Medical Center MVZ Bad Sobernheim, Germany.

Medical Center MVZ Bad Sobernheim doctors specialize in orthopedic surgery, physical and rehabilitative medicine and more generally the medical care of musculo-skeletal pathologies. A section of MVZ specializes in the diagnosis and conservative treatment of spinal deformities, primarily scoliosis.

Dr. Christof Verres, a physical and rehabilitative medicine specialist at MVZ Sobernheim, said, "We are focused on the conservative treatment of spinal pathologies including scoliosis and specialize in the use of correction braces. Brace treatment progress is consistently monitored and adapted and requires frequent follow up exams. In less than 20 seconds, the EOS system provides a streamlined image of our patients in a functional standing position, all under greatly reduced radiation exposure. Short imaging times and low minimal exposure are great for our young patients, while the 3D will be incredibly helpful in treatment planning and in monitoring effectiveness.”

Marie Meynadier, CEO of EOS imaging, said, "We are pleased to install our first private EOS imaging installation in Germany at the Medical Center MVZ Bad Sobernheim. Conservative treatment of scoliosis with bracing was recently highlighted by a major study¹ as beneficial for patients at risk of progression. Such treatments require frequent monitoring for which EOS provides the right low dose solution. We are also eager to help brace manufacturers and technicians design the most efficient bracing solutions based on EOS 3D information.”

For further information about the Company or EOS®, the first full-body, low dose 2D/3D imaging system, please visit www.eos-imaging.com.

¹Weinstein, SL, et al. Effects of Bracing in Adolescents with Idiopathic Scoliosis, 2013. New England Journal of Medicine, 1512-1521, 369, 16, doi:10.1056/NEJMoa1307337, 24047455. http://www.nejm.org/doi/full/10.1056/NEJMoa1307337

About EOS imaging:
EOS imaging designs, develops, and markets EOS®, a revolutionary and patented medical imaging system, based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Company is authorized to market the system in 31 countries, including the United States (FDA), Japan, Canada, Australia and the European Union (EU). Backed by an installed base of 70 sites and more than 400,000 imaging sessions, EOS® benefits from worldwide recognition within the global medical community. As of December 31, 2012 the Group posted 2012 consolidated revenue of €9.42 million and employs 70 people including an R&D team of 25 engineers. The Group is based in Paris and holds three subsidiaries in Cambridge (Massachusetts), in Canada at Montreal and in Germany, and offices in Singapore.

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

Next press release: Annual results 2013 on January 22, 2014 (after market).